Lymphoseek

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2009
012320032009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
Oral cavity squamous cell carcinoma (OCSCC) has a yearly incidence of 274,000 patients. Twenty percent to 30% of patients will… (More)
Is this relevant?
2009
2009
Lymphoseek is a receptor-binding radiopharmaceutical specifically designed for sentinel lymph node (SLN) mapping. We conducted a… (More)
Is this relevant?
2007
2007
Lymphoseek is a molecular imaging agent specifically designed for sentinel lymph node (SLN) mapping. We conducted a Phase I trial… (More)
Is this relevant?
2006
2006
Lymphoseek is a molecular imaging agent specifically designed for sentinel lymph node mapping. We conducted a phase I clinical… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2006
2006
BACKGROUND Minimally invasive surgery and sentinel node mapping are being utilized increasingly in colon cancer surgery. Making… (More)
Is this relevant?
2006
2006
PURPOSE SLN identification could improve the pathological staging of prostate cancer. Prior SLN studies have been compromised by… (More)
Is this relevant?
2004
2004
Background: Lymphoseek is a radiopharmaceutical designed for sentinel lymph node (SLN) mapping. The purpose of this study was to… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
2003
2003
Background: Lymphoseek is a new radiopharmaceutical that accumulates in lymphatic tissue by binding to a receptor that resides on… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 3
Is this relevant?